Pediatric cardiac surgery associated-acute kidney injury: Interleukin 18 as a new biomarker

Ronke Adunni Makinde1, Abiodun Olabamiji Ajose2, Abiodun Kofoworola Ajeigbe2

  • 1Department of Chemical Pathology, Obafemi Awolowo University Teaching Hospital Complex, Ile ife 220282, Osun, Nigeria. ronkeomoola@yahoo.com.

Insights

Interleukin 18 (IL-18) shows higher sensitivity and specificity for detecting cardiac surgery-associated (CSA) acute kidney injury (AKI) in children compared to creatinine. This new marker offers a more accurate and timely diagnosis for pediatric AKI post-surgery.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Surgery
  • Biomarker Discovery

Background:

  • Creatinine is the standard but delayed marker for cardiac surgery-associated (CSA) acute kidney injury (AKI).
  • Delayed AKI diagnosis in pediatric patients hinders effective treatment and prevention strategies.
  • There is a critical need for more sensitive and rapid AKI biomarkers in pediatric cardiac surgery.

Purpose of the Study:

  • To evaluate the diagnostic performance of interleukin 18 (IL-18) against creatinine for detecting AKI in Nigerian children post-cardiac surgery.
  • To compare the sensitivity and specificity of IL-18 and creatinine in identifying pediatric CSA-AKI.

Main Methods:

  • Plasma samples were collected from 40 pediatric patients (<15 years) undergoing open-heart surgery.
  • Samples were analyzed for IL-18 and creatinine at six time points within 48 hours post-surgery.
  • IL-18 was measured using ELISA, and creatinine was measured using the automated Jaffe kinetic method.

Main Results:

  • Plasma IL-18 concentrations peaked at 8 hours post-surgery, reaching an average of 22.15 ng/L.
  • IL-18 demonstrated high diagnostic accuracy for CSA-AKI, with 100% sensitivity and 88% specificity at a 22 ng/L threshold.
  • The area under the receiver operating characteristic curve (AUC) for IL-18 was 0.926, indicating excellent performance.

Conclusions:

  • Interleukin 18 (IL-18) is a more sensitive and specific biomarker for detecting CSA-AKI in pediatric patients than creatinine.
  • IL-18 offers a promising tool for early and accurate diagnosis of AKI in children following cardiac surgery.
  • Findings support the potential clinical utility of IL-18 for improved management of pediatric CSA-AKI.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...